Literature DB >> 9271631

HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy.

M C Ellis1, A H Hetisimer, D A Ruddy, S L Hansen, G S Kronmal, E McClelland, L Quintana, D T Drayna, M S Aldrich, E Mignot.   

Abstract

A systematic haplotype and sequencing analysis of the HLA-DR and -DQ region in patients with narcolepsy was performed. Five new (CA)n microsatellite markers were generated and positioned on the physical map across the HLA-DQB1-DQA1-DRB1 interval. Haplotypes for these new markers and the three HLA loci were established using somatic cell hybrids generated from patients. A four-marker haplotype surrounding the DQB1(*)0602 gene was found in all narcolepsy patients, and was identical to haplotypes observed on random chromosomes harboring the DQB1(*)0602 allele. Eighty-six kilobases of contiguous genomic sequence across the region did not reveal new genes, and analysis of this sequence for single nucleotide polymorphisms did not reveal sequence variation among DQB1(*)0602 chromosomes. These results are consistent with other studies, suggesting that the HLA-DQ genes themselves are among the predisposing factors in narcolepsy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271631     DOI: 10.1007/s002510050295

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  10 in total

1.  High-density map of short tandem repeats across the human major histocompatibility complex.

Authors:  Michael Cullen; Michael Malasky; Anita Harding; Mary Carrington
Journal:  Immunogenetics       Date:  2003-02-21       Impact factor: 2.846

Review 2.  The quest for better understanding of HLA-disease association: scenes from a road less travelled by.

Authors:  Joseph Holoshitz
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

3.  Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.

Authors:  Justin P Rubio; Melanie Bahlo; Jim Stankovich; Rachel K Burfoot; Laura J Johnson; Stewart Huxtable; Helmut Butzkueven; Ling Lin; Bruce V Taylor; Terence P Speed; Trevor J Kilpatrick; Emmanuel Mignot; Simon J Foote
Journal:  Immunogenetics       Date:  2007-01-26       Impact factor: 2.846

Review 4.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

5.  Genetic and environmental contributions to stability and change of sleep problems in toddlerhood.

Authors:  Manjie Wang; Kimberly J Saudino
Journal:  J Pediatr Psychol       Date:  2012-03-15

6.  HLA dosage effect in narcolepsy with cataplexy.

Authors:  Astrid van der Heide; Willem Verduijn; Geert W Haasnoot; Jos J M Drabbels; Gert J Lammers; Frans H J Claas
Journal:  Immunogenetics       Date:  2014-10-03       Impact factor: 2.846

7.  Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups.

Authors:  E Mignot; L Lin; W Rogers; Y Honda; X Qiu; X Lin; M Okun; H Hohjoh; T Miki; S Hsu; M Leffell; F Grumet; M Fernandez-Vina; M Honda; N Risch
Journal:  Am J Hum Genet       Date:  2001-02-13       Impact factor: 11.025

Review 8.  History of narcolepsy at Stanford University.

Authors:  Emmanuel J M Mignot
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

Review 9.  HLA-G and the MHC Cusp Theory.

Authors:  Bruna Miglioranza Scavuzzi; Vincent van Drongelen; Joseph Holoshitz
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

10.  Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexican patients: a relationship between HLA and gender is suggested.

Authors:  Carmen Alaez; Ling Lin; Hilario Flores-A; Miriam Vazquez; Andrea Munguia; Emmanuel Mignot; Reyes Haro; Harry Baker; Clara Gorodezky
Journal:  BMC Med Genet       Date:  2008-08-15       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.